Phorbol ester-induced, cell-cycle-specific, growth inhibition of human B-lymphoma cell lines
- PMID: 2313723
- DOI: 10.1093/jnci/82.6.501
Phorbol ester-induced, cell-cycle-specific, growth inhibition of human B-lymphoma cell lines
Abstract
The activation, growth, and differentiation of three B-cell- and one non-B-cell-derived human lymphoma cell lines were examined after treatment with protein kinase C-activating phorbol esters. Treatment with these agents resulted in early activation events similar to those observed in normal B cells. However, in contrast to their growth-promoting effect on normal human B lymphocytes, exposure to these phorbol esters induced profound growth inhibition of the three B-cell-derived lymphoma lines. Maximal inhibition was achieved within 24 hours of culture initiation and could be reversed if the phorbol ester was removed after 12, but not 20, hours in culture. Cell-cycle analysis of phorbol ester-treated lymphoma cells revealed a G1/S block in one line, whereas cells from the other two lines accumulated in G2/M. These data demonstrate that protein kinase C-binding phorbol esters can interrupt the cell cycle in two places in actively dividing human B-lymphoma cells. These findings may prove valuable with regard to potential therapy of human malignant lymphomas.
Similar articles
-
Lymphoma models for B cell activation and tolerance. V. Anti-Ig mediated growth inhibition is reversed by phorbol myristate acetate but does not involve changes in cytosolic free calcium.J Mol Cell Immunol. 1987;3(2):109-20. J Mol Cell Immunol. 1987. PMID: 3509921
-
Role of phosphoinositide-derived second messengers in mediating anti-IgM-induced growth arrest of WEHI-231 B lymphoma cells.J Immunol. 1988 Jun 1;140(11):3717-26. J Immunol. 1988. PMID: 2836499
-
Selective induction of high levels of IgA synthesis in Peyer's patch B cells by protein kinase C-activating phorbol esters.J Immunol. 1991 Sep 15;147(6):1752-8. J Immunol. 1991. PMID: 1909730
-
Phorbol esters and growth regulation in metastatic melanoma cells.Cancer Treat Res. 1991;54:67-83. doi: 10.1007/978-1-4615-3938-4_4. Cancer Treat Res. 1991. PMID: 1673860 Review. No abstract available.
-
Regulation of cell division of mature B cells by ionomycin and phorbol ester.J Immunol. 1992 Mar 15;148(6):1797-803. J Immunol. 1992. PMID: 1541820
Cited by
-
STAT6 mutations enriched at diffuse large B-cell lymphoma relapse reshape the tumor microenvironment.Int J Hematol. 2024 Mar;119(3):275-290. doi: 10.1007/s12185-023-03692-x. Epub 2024 Jan 29. Int J Hematol. 2024. PMID: 38285120 Free PMC article.
-
Loss of fragile WWOX gene leads to senescence escape and genome instability.Cell Mol Life Sci. 2023 Oct 28;80(11):338. doi: 10.1007/s00018-023-04950-1. Cell Mol Life Sci. 2023. PMID: 37897534 Free PMC article.
-
Ras interacting protein 1 facilitated proliferation and invasion of diffuse large B-cell lymphoma cells.Cancer Biol Ther. 2023 Dec 31;24(1):2193114. doi: 10.1080/15384047.2023.2193114. Cancer Biol Ther. 2023. PMID: 36967521 Free PMC article.
-
Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models.Nat Commun. 2018 May 22;9(1):2024. doi: 10.1038/s41467-018-04356-9. Nat Commun. 2018. PMID: 29789628 Free PMC article.
-
Viral microRNA effects on persistent infection of human lymphoid cells by polyomavirus SV40.PLoS One. 2018 Feb 12;13(2):e0192799. doi: 10.1371/journal.pone.0192799. eCollection 2018. PLoS One. 2018. PMID: 29432481 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials